Starna Therapeutics
PrivateLast Round
Series B
Extension
May 11, 2026
Total Funding Raised
$108M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Starna Therapeutics operates in Healthcare & Life Sciences and is based in Suzhou. Its latest recorded funding round was a Series B Extension round in May 2026.
Starna Therapeutics is a biotechnology company that develops innovative RNA-based drugs and vaccines using its proprietary extrahepatic targeted delivery technology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Infrastructure
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Starna Therapeutics Comparables
Compare Starna Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CREATE Medicines | 86% | |
| Immorna | 84% | |
| Immorna Biotherapeutics | 84% |
For institutional investors. Book with your work email.
Starna Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | May 11, 2026 | ||||
| Series B | Oct 22, 2025 | ||||
| Series A | May 16, 2022 | ||||
| Angel | Dec 1, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Starna Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Primavera Venture Partners | Series A |
| Hillhouse Investment | Series A, Angel, Series B Extension, Series B |
| LYFE Capital | Series B Extension, Series A, Series B |
| Hony Capital | Series A |
| Source Code Capital | Series A, Series B, Series B Extension |
| Primavera Venture Partners | Series A |
| Lilly Asia Ventures | Series B Extension, Series B |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 27, 2026
Monthly visitors increased 251% MoM.
- May 11, 2026
$40M raised with participation from Lilly Asia Ventures and others.
For institutional investors. Book with your work email.
Starna Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Starna Therapeutics's valuation, stock price, and market status.
Is Starna Therapeutics a public or private company?
Starna Therapeutics is a private company.
What is the current stock price of Starna Therapeutics?
Starna Therapeutics is a private company, so its shares have no public market price. Caplight tracks Starna Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Starna Therapeutics worth (valuation)?
Valuation information for Starna Therapeutics is not publicly available.
Can I buy Starna Therapeutics stock?
Starna Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Starna Therapeutics's last funding round?
Starna Therapeutics's most recent funding round was Series B Extension on May 11, 2026.
Who are the main investors in Starna Therapeutics?
Key investors in Starna Therapeutics include Hillhouse Investment, LYFE Capital, Lilly Asia Ventures.
Will Starna Therapeutics IPO soon?
No public IPO plans have been announced for Starna Therapeutics.
How can I track Starna Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Starna Therapeutics's shares on secondary markets.